A CASE OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED PLA2R MEMBRANOUS NEPHROPATHY AND CONCURRENT ACUTE INTERSTITIAL NEPHRITIS TREATED WITH ANTI-CD20 THERAPY

被引：0
|
作者：
Ahmad, Syeda [1 ]
Kaldas, Hoda [1 ]
Sethi, Sanjeev [2 ]
机构：
[1] Univ Pittsburgh, Renal & Elect Dept, Med Ctr, Pittsburgh, PA USA
[2] Mayo Clin, Rochester, MN USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2023年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
315
引用
下载
收藏
页码：S92 / S93
页数：2
相关论文
共 10 条
  • [1] Treatment of PLA2R-Negative Membranous Nephropathy in the Setting of Immune Checkpoint Inhibitor and Renal Cell Carcinoma
    Reddy, Vikas D.
    Kala, Jaya
    Msaouel, Pavlos S.
    Glass, William F.
    Mamlouk, Omar
    Abudayyeh, Ala
    Lin, Jamie S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 575 - 575
  • [2] ANTI-PLA2R Positive Membranous Nephropathy Associated With Atezolizumab: A Case Report
    Oleas, Diana
    Tapia, Irati
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 381 - 381
  • [3] Anti-PLA2R Membranous Nephropathy Associated With Multiple Sclerosis: First Case Report
    Cunha, Milena V.
    Silveira, Vinicius S.
    Souza, Lucas A.
    Silva, Guilherme D.
    Lucato, Leandro T.
    Cavalcante, Livia B.
    Jorge, Lecticia
    Dias, Cristiane B.
    Noronha, Irene L.
    Yu, Luis
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 193 - 194
  • [4] Anti-glomerular basement membrane glomerulonephritis concurrent with membranous nephropathy and acute tubular interstitial nephritis in a lung cancer patient treated with pembrolizumab
    Hoshina, Azusa
    Endo, Shuichiro
    CEN CASE REPORTS, 2023, 12 (02) : 230 - 236
  • [5] Anti-glomerular basement membrane glomerulonephritis concurrent with membranous nephropathy and acute tubular interstitial nephritis in a lung cancer patient treated with pembrolizumab
    Azusa Hoshina
    Shuichiro Endo
    CEN Case Reports, 2023, 12 : 230 - 236
  • [6] ANTI-PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R)-NEGATIVE MEMBRANOUS NEPHROPATHY ASSOCIATED WITH OMENTAL MESOTHELIOMA AND RETROPERITONEAL FIBROSIS
    Cohen, A.
    Vilayur, E.
    NEPHROLOGY, 2021, 26 : 49 - 50
  • [7] Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression
    Stehle, Thomas
    Grimbert, Philippe
    Remy, Philippe
    Moktefi, Anissa
    Audard, Vincent
    El Karoui, Khalil
    KIDNEY INTERNATIONAL, 2022, 101 (02) : 416 - 418
  • [8] LOW DOSE PREDNISOLONE WITH TACROLIMUS IS EFFECTIVE THERAPY FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY AND CHANGES IN ANTI-PLA2R IS ASSOCIATED WITH RESPONSE TO THERAPY
    Prasad, Narayan
    Jaiswal, Akhilesh
    Singh, Harshit
    Agarwal, Vikas
    Singh, Mantabya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 92 - 92
  • [9] Circulating (CD3-CD19+CD20-IgD-CD27highCD38high) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
    Pozdzik, Agnieszka
    Beukinga, Ingrid
    Gu-Trantien, Chunyan
    Willard-Gallo, Karen
    Nortier, Joelle
    Pradier, Olivier
    MEDIATORS OF INFLAMMATION, 2016, 2016
  • [10] Multiomic Biological mOdifications in the immune response of patients treated with chemotherapy, anti-CD20, or immune-checkpoint inhibitors and receiving a Third dose of vaccinE against SARS-CoV-2 (the BO0STER study)
    Zoppoli, G.
    Ferrando, L.
    Ravera, F.
    Dameri, M.
    Lombardo, I.
    Stabile, M.
    Fallani, N.
    Cigolini, B.
    Gentilcore, G.
    Bruzzone, B.
    Domnich, A.
    Orsi, A.
    Ballerini, F.
    Rinchai, D.
    Chaussabel, D.
    Bedognetti, D.
    Grivel, J-C.
    Genova, C.
    Lemoli, R.
    Ballestrero, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1172 - S1172
1